| Ytd | -64.54% | |
| 1y | -75.74% |
| Open | 0.36 | Prev Close | 0.35 | Low | 0.35 | High | 0.37 | Mkt Cap | 11.49M |
| Vol | 92.67K | Avg Vol | 250.33K | EPS | -1.77 | P/E | -0.21 | Forward P/E | -5.33 |
| Beta | 2.10 | Short Ratio | 3.27 | Inst. Own | 23.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.77 | 200-d Avg | 1.11 | 1yr Est | 12.00 |
SNTI News
Senti Biosciences (NASDAQ: SNTI - Get Free Report) will likely be issuing its Q2 2026 results before
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday
Senti Biosciences Holdings, Inc. (NASDAQ: SNTI) ("SBH" or the "Company") today annou
SOUTH SAN FRANCISCO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences Holdings, Inc. (NAS
Secured strategic financing vehicle for up to $40 million Positive FDA feedback supports single-arm
Following a Type B meeting with FDA, Senti Bio plans to proceed with a single-arm multi-center regis
SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNT
SOUTH SAN FRANCISCO, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNT
SOUTH SAN FRANCISCO, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNT
Shares of Senti Biosciences, Inc. (NASDAQ: SNTI - Get Free Report) have received an average rating o
SOUTH SAN FRANCISCO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNT
SOUTH SAN FRANCISCO, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNT
Senti Biosciences, Inc. (NASDAQ: SNTI - Get Free Report) has been given an average rating of "Modera
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI
Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable comple
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI
Access the segment here
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI
Senti Biosciences, Inc. (NASDAQ: SNTI - Get Free Report) has been given an average recommendation of
RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patie
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the pu
During Thursday's session, 99 companies made new 52-week lows.
On Monday, 141 companies reached new 52-week lows.
On Wednesday, 220 stocks hit new 52-week lows.
On Monday, 198 companies hit new 52-week lows.
Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Hea
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda
Monday saw 825 companies set new 52-week lows.
On Wednesday, 340 stocks hit new 52-week lows.
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKin
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.
Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.
On Friday, 137 stocks made new 52-week lows.
On Tuesday, 186 companies set new 52-week lows.
Wednesday's session saw 269 companies set new 52-week lows.
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on
During Monday's trading, 1214 companies set new 52-week lows.
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the com